ERBB2 and neoplasm: Other factors, such as younger age, higher histological grade, presence of LVI, larger tumor size, macrometastases in SLN, the number of positive and negative SLN, and HER2 overexpression, have also been suggested to influence the risk of non-SLN metastases [65,68].